Commitments (Details) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Sep. 23, 2024 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Commitments [Line Items] | ||||
| Development milestone payments | $ 1,594,000 | $ 2,206,000 | ||
| Cash | 6,500,000 | |||
| Expected Cost | 6,500,000 | |||
| Actual cost | 6,500,000 | |||
| Deferred income | 1,530,000 | $ 1,269,000 | ||
| Clinical Trial Management Agreement [Member] | ||||
| Commitments [Line Items] | ||||
| Deferred income | $ 975 | |||
| Medicox License Agreement [Member] | ||||
| Commitments [Line Items] | ||||
| Fixed consideration | $ 11,577,000 | |||
| Development milestone payments | $ 16,000 | |||
| Minimum [Member] | ||||
| Commitments [Line Items] | ||||
| Lease payments | 3.00% | |||
| Maximum [Member] | ||||
| Commitments [Line Items] | ||||
| Lease payments | 7.00% | |||
| X | ||||||||||
- Definition The amount of actual cost. No definition available.
|
| X | ||||||||||
- Definition The amount of expected cost. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Discount rate used by lessee to determine present value of operating lease payments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|